ALB and chronic kidney disease: The inclusion of chronic kidney disease, estimated glomerular filtration rate measurement, and urine albumin-to-creatinine ratio should be considered as endpoints in atrial fibrillation, as should conventional major adverse cardiovascular events components, and integrated cardiorenal treatment should be prioritized.